Dữ liệu Xếp hạng Học thuật WoS SCIE & CAS
Bảng Xếp hạng Tạp chí Khoa học Toàn cầu
Khám phá thứ bậc học thuật, đối chiếu chỉ số Clarivate Impact Factor, phân hạng Web of Science Q1–Q4 và phân vùng CAS.
Hiển thị 76–100 của 232 tạp chí khoa học quốc tế (Oncology)
| Hạng | Tên Tạp chí & Mã ISSN | Impact Factor | H-Index | Phân hạng WoS | Scopus SJR | Phân vùng CAS | Tự trích dẫn | Số bài/năm | Nhà xuất bản |
|---|---|---|---|---|---|---|---|---|---|
| #76 | JTO Clinical and Research Reports ISSN: 2666-3643 | 3.6 | 31 | Q2 | 1.708Q1 | CAS Tier 2 | 3.3% | 108 | Elsevier |
| #77 | Journal of Bone Oncology ISSN: 2212-1366 / 2212-1374 | 3.6 | 46 | Q2 | 1.087Q2 | CAS Tier 3 | 3.2% | 62 | Elsevier GmbH |
| #78 | Journal of Breast Cancer ISSN: 1738-6756 | 3.6 | 55 | Q2 | 0.89Q2 | CAS Tier 4 | 4.5% | 52 | Korean Breast Cancer Society |
| #79 | Precision Radiation Oncology ISSN: 2398-7324 | 3.6 | 14 | Q1 | 0.746Q2 | CAS Tier 4 | N/A | 41 | Wiley |
| #80 | Radiation Oncology ISSN: 1748-717X | 3.6 | 102 | Q2 | 1.05Q1 | CAS Tier 2 | 6.1% | 236 | BioMed Central |
| #81 | World Journal of Clinical Oncology ISSN: 2218-4333 | 3.6 | — | Q2 | — | CAS Tier 3 | 0% | 89 | Baishideng Publishing Group |
| #82 | Cancer Medicine ISSN: 2045-7634 | 3.5 | 105 | Q2 | 1.156Q1 | CAS Tier 3 | 3.4% | 772 | John Wiley and Sons Ltd |
| #83 | Cancer Treatment and Research Communications ISSN: 2468-2942 | 3.5 | 35 | Q2 | 0.995Q2 | CAS Tier 4 | N/A | 320 | Elsevier |
| #84 | Cancer Prevention Research ISSN: 1940-6207 / 1940-6215 | 3.4 | 120 | Q2 | 1.129Q1 | CAS Tier 3 | 3.4% | 102 | American Association for Cancer Research Inc. |
| #85 | Journal of Cancer ISSN: 1837-9664 | 3.4 | 99 | Q2 | 0.852Q2 | CAS Tier 3 | 0% | 710 | Ivyspring International Publisher |
| #86 | Journal of Cancer Survivorship ISSN: 1932-2259 / 1932-2267 | 3.4 | 93 | Q2 | 1.151Q1 | CAS Tier 2 | 6.5% | 155 | Springer US |
| #87 | Oncology and Therapy ISSN: 2366-1070 / 2366-1089 | 3.4 | 24 | Q2 | 1.159Q2 | CAS Tier 3 | 0% | 42 | Adis, Springer Healthcare |
| #88 | Translational Lung Cancer Research ISSN: 2218-6751 | 3.4 | 78 | Q2 | 0.987Q2 | CAS Tier 3 | 5% | 354 | Society for Translational Medicine (STM) |
| #89 | Breast Cancer Research and Treatment ISSN: 0167-6806 / 1573-7217 | 3.3 | 189 | Q2 | 1.34Q1 | CAS Tier 3 | 6.7% | 398 | Springer US |
| #90 | Journal of Cancer Research and Clinical Oncology ISSN: 0171-5216 / 1432-1335 | 3.3 | 118 | Q2 | 0.954Q1 | CAS Tier 3 | 3.7% | 362 | Springer Berlin Heidelberg |
| #91 | Lung Cancer: Targets and Therapy ISSN: 1179-2728 | 3.3 | 32 | Q2 | 1.028Q2 | CAS Tier 3 | N/A | 8 | Dove Medical Press |
| #92 | Blood and Lymphatic Cancer-Targets and Therapy ISSN: 1179-9889 | 3.2 | — | Q2 | — | CAS Tier 3 | 0% | 6 | Dove Medical Press |
| #93 | Infectious Agents and Cancer ISSN: 1750-9378 | 3.2 | 54 | Q3 | 0.92Q2 | CAS Tier 3 | 3.2% | 66 | BioMed Central |
| #94 | American Journal of Cancer Research ISSN: 2156-6976 | 3.1 | 20 | Q2 | — | CAS Tier 3 | 2.8% | 381 | E-CENTURY PUBLISHING CORP |
| #95 | Cancer Control ISSN: 1073-2748 / 1526-2359 | 3.1 | 88 | Q2 | 0.907Q1 | CAS Tier 3 | 4% | 133 | H. Lee Moffitt Cancer Center and Research Institute |
| #96 | Future Oncology ISSN: 1479-6694 / 1744-8301 | 3.1 | 102 | Q2 | 1.229Q1 | CAS Tier 4 | 3.3% | 390 | Future Medicine Ltd. |
| #97 | Journal of Immunotherapy and Precision Oncology ISSN: 2666-2345 / 2590-017X | 3.1 | 15 | Q3 | 1.37Q1 | CAS Tier 4 | N/A | 6 | Innovative Healthcare Institute |
| #98 | Cancer Epidemiology ISSN: 1877-7821 / 1877-783X | 3 | 94 | Q3 | 1.036Q2 | CAS Tier 3 | 4.2% | 144 | Elsevier BV |
| #99 | Expert Review of Anticancer Therapy ISSN: 1473-7140 / 1744-8328 | 3 | 91 | Q3 | 0.84Q2 | CAS Tier 3 | 0% | 99 | Taylor and Francis Ltd. |
| #100 | International Journal of Clinical Oncology ISSN: 1341-9625 / 1437-7772 | 3 | 83 | Q3 | 0.945Q1 | CAS Tier 3 | 0% | 239 | Springer Singapore |